Table 2.
Clinical practice guideline author agreement with Rules Document
| Rule Category | Agreement (%) | Clarification (%) | ||
|---|---|---|---|---|
| Round one | Round two | Round one | Round two | |
| Drug recommendations overall | 82 | 79 | 24 | 21 |
| 1) Initiation dosing | 93 | 43 | 7 | 64 |
| 2) Titration dosing | 89 | 89 | 11 | 0 |
| 3) Switching dosing | 100 | 100 | 14 | 0 |
| 4) Cessation dosing | 28 | 100 | 86 | 0 |
| 5) Medication choice | - | 100 | - | 0 |
| Contraindications/warnings overall | 84 | 86 | 44 | 12 |
| 1) Medical contraindications | 80 | 69 | 75 | 0 |
| 2) Psychiatric contraindications | 94 | 89 | 30 | 15 |
| 3) Psychosocial contraindications | 63 | 100 | 47 | 0 |
| Patient eligibility and exclusion | 66 | 100 | 44 | 0 |
% Agreement indicates the percentage of rules in each category for which all three authors indicated agreement. % Clarification indicates the percentage of rules in each category where at least one author identified problems with the rule that needed to be addressed to ensure agreement with the CPG.